(PTIX - PROTAGENIC THERAPEUTICS INC)

company profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Protagenic Therapeutics (PTIX) is trading at 0.3921

Open Price

0.4051

Previous close

0.3921

Previous close

0.3921

P/E Ratio

0

Sector

Health Care

Shares outstanding

1810208

Primary exchange

OTC Markets

ISIN

US74365N3017